Michael Gelband’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Michael Gelband’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,125	Closed	-$161K	–	2238
2022 Q4	$161K	Buy	+13,125	New	+$313K	﹤0.01%	1484

Michael Gelband's CINC Position: Q1 2023 in Review

Michael Gelband sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 13,125 shares — an estimated $161K sold.

Michael Gelband first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $161K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Michael Gelband reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Michael Gelband sold 13,125 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $161K.
Michael Gelband first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Michael Gelband's CinCor Pharma, Inc. Common Stock position peaked at $161K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on ExodusPoint Capital Management's 13F filing for Q1 2023, filed 11 May 2023.